Dr Florian Kaiser, Head of the Quantum Materials group at the Luxembourg Institute of Science and Technology (LIST), has been awarded a prestigious ERC Consolidator Grant worth €3 million. This grant will fund his research project, “Q-Chip”, which aims to demonstrate that quantum processors and quantum memories can be operated simultaneously on a single chip, thus overcoming existing scalability challenges in quantum technologies.

The project will build on groundbreaking research, also led by Dr Kaiser and his team, that explores silicon carbide's potential to significantly improve scalability in quantum computing. On completion, this project will drive a major shift towards reliable, affordable, and widely accessible quantum technologies.

Data constantly changes. For instance, the name of the current German Chancellor can change faster than expected. Machine learning models must adapt to new knowledge and continually improve their ability to solve different tasks. To date, this has typically meant they need to be retrained regularly. This is not only expensive but also demands enormous computational power, costing society much more than just money. CISPA-Faculty Dr. Sebastian Stich aims to address this with his research project "Collective Minds," which seeks to develop new algorithms for more sustainable and efficient machine learning. According to Stich, the key is better collaboration. The European Research Council (ERC) will fund his project for the next five years with approximately two million euros.

Theta burst stimulation (TBS) is a non-invasive brain stimulation technique known for modifying human behavior and treating neurological diseases. A group of scientists, led by Dr. Taro Kishi, a Professor from Fujita Health University, conducted a systematic review and network meta-analysis to determine the effective TBS protocols for addressing schizophrenia symptoms and cognitive impairment. Their findings suggest that intermittent TBS over the left dorsolateral prefrontal cortex may offer a promising alternative to antipsychotic drug-based treatment.